Catarax eye drops 0.015% 15ml №1

Name:
Kataraks drops hl.rr 0.015% in a 15ml vial-cap. in pack No. 1
Description:
Eye drops, solution 0.015% bright red, transparent, does not contain mechanical impurities. The main active ingredient is azapentacene Form of release eye drops, solution 0.015%: vial. 15 ml 1 piece Dosage The recommended dose is 2 drops of Catarax, which is instilled into the conjunctival sac of the affected eye(s) 3 to 5 times a day. It is recommended to continue treatment even if rapid clinical improvement occurs. Special instructions Patients using contact lenses should use Catarax only with the lenses removed and install them again 15 minutes after instillation of the drug. After each use of the drug, close the vial. Do not touch the tip of the dropper to the eye. Use in Pediatrics There is no sufficient experience with the use of Catarax in children. Perhaps the use of Catarax in children in the case when the expected therapeutic effect outweighs the potential risk of possible side effects. Influence on the ability to drive vehicles and control mechanisms Patients who, after instillation, have temporary visual impairment, are not recommended to drive a car or work with complex machinery, machines or any other complex equipment that requires clarity of vision immediately after instillation of the drug. Pharmacological actionKatarax slows down the degeneration of the lens, preventing or slowing down the development of cataracts. Stimulates proteolytic enzymes contained in the aqueous humor of the anterior chamber of the eye; inhibits the formation of quinoid compounds and prevents their damaging effect on lens proteins Indications for use senile cataract; traumatic cataract; congenital cataract; secondary cataract. Dosage and administration The drug is instilled into the affected eye 1-2 drops 3-5 times / day. The drug is intended for long-term therapy. Treatment should not be interrupted even in the event of a rapid clinical improvement. Use during pregnancy and lactation There is no sufficient experience with the use of Catarax during pregnancy and lactation (breastfeeding). Perhaps the use of Catarax in pregnant women and nursing mothers in the case when the expected therapeutic effect outweighs the potential risk of possible side effects in the fetus or child. Interaction with other drugs At present, interaction with other drugs has not been established. Contraindications Hypersensitivity to the components of the drug. Ingredients Eye drops, solution 0.015% bright red, transparent, does not contain mechanical impurities. 1 ml azapentacene sodium polysulfonate 150 mcg Excipients: boric acid, sodium tetraborate decahydrate, potassium chloride, thiomersal, methyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium hydroxide 10% solution, purified water. 15 ml – plastic dropper bottles (1) – cardboard boxes. Overdose In case of accidental ingestion, no symptoms of overdose have been established. Excess drug can be removed from the eye with warm running water. Side effects When used according to indications in recommended doses, side effects were not detected. Storage conditions The drug should be stored in its original packaging out of the reach of children at a temperature of 15-25°C. Buy Catarax eye drops 0.015% 15ml №1 Price for Catarax eye drops 0.015% 15ml №1